A5076636649- HIV, Drug Use, Sexual Risk
- HIV/AIDS Research and Interventions
- Sex work and related issues
- Homelessness and Social Issues
- Adolescent Sexual and Reproductive Health
- Criminal Justice and Corrections Analysis
- Intimate Partner and Family Violence
- Opioid Use Disorder Treatment
- HIV Research and Treatment
- COVID-19 epidemiological studies
- Hepatitis C virus research
- Substance Abuse Treatment and Outcomes
- COVID-19 and Mental Health
- Mobile Health and mHealth Applications
- Prenatal Substance Exposure Effects
- Homicide, Infanticide, and Child Abuse
- Telemedicine and Telehealth Implementation
- Vaccine Coverage and Hesitancy
- COVID-19 Digital Contact Tracing
- HIV/AIDS oral health manifestations
- Maternal Mental Health During Pregnancy and Postpartum
- Psychopathy, Forensic Psychiatry, Sexual Offending
- Migration, Health and Trauma
- HIV/AIDS drug development and treatment
- Medication Adherence and Compliance
Yale University
2016-2025
University of New Haven
2025
Yale Cancer Center
2017
George Mason University
2015
New York City Department of Health and Mental Hygiene
2014
University of Illinois Chicago
2014
University School
2014
The University of Texas Health Science Center at Houston
1996
In the United States, 10 million inmates are released every year, and human immunodeficiency virus (HIV) infection acquired syndrome (AIDS) prevalence is several-fold greater in criminal justice populations than community. Few effective linkage-to-the-community programs currently available for prisoners infected with HIV. As a result, combination antiretroviral therapy (cART) seldom continued after release, virological immunological outcomes worsen. Poor HIV treatment result from myriad of...
Human immunodeficiency virus (HIV) management in correctional settings is logistically feasible, but HIV-related outcomes before release have not been recently systematically examined.To evaluate HIV treatment throughout incarceration, including jail and prison.Retrospective cohort study of longitudinally linked demographic, pharmacy, laboratory data on 882 prisoners within the Connecticut Department Correction (2005-2012) with confirmed infection, who were continually incarcerated 90 days...
Objectives. We assessed gender differences in longitudinal HIV treatment outcomes among HIV-infected jail detainees transitioning to the community. Methods. Data were from largest multisite prospective cohort study of released (n = 1270)—the Enhancing Linkages Primary Care and Services Jail Setting Initiative, January 2008 March 2011, which had 10 sites 9 states. baseline 6-month outcomes, stratifying by gender. Results. Of 867 evaluable participants, 277 (31.9%) women. Compared with men,...
Introduction: Scaling up vaccination against COVID-19 is central to controlling the epidemic in United States. Several vaccines are now approved for prevention of COVID-19, but public concerns over safety and efficacy have heightened distrust vaccine hesitancy. This particularly concerning among people with HIV (PWH) who may be vulnerable more severe disease. Here, we aimed identify understand hesitancy a sample PWH U.S. Methods: We conducted cross-sectional online survey between 6 December...
Oral pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate (F/TDF) has high efficacy against HIV-1 acquisition. Seventy-two prospective studies of daily oral F/TDF PrEP were conducted to evaluate incidence, drug resistance, adherence, and bone renal safety in diverse settings. incidence was calculated from incident diagnoses after initiation within 60 days discontinuation. Tenofovir concentrations dried blood spots (DBS), bone/renal indicators evaluated a subset...
Women involved in the criminal justice system (WICJ) are at high risk of acquiring HIV and would benefit from pre-exposure prophylaxis (PrEP) but there no studies this population to inform PrEP implementation programs. We conducted a cross-sectional survey HIV-uninfected, cis-gender women on probation, parole and/or recently released prison/jail assess awareness, eligibility, potential barriers uptake, care continuum. The 125 WICJ surveyed reported rates behaviors including recent...
The criminal justice system bears a disproportionate burden of the HIV epidemic. Continuity care is critical for HAART-based prevention HIV-related morbidity and mortality. This paper describes four major challenges to successful management in system: relapse substance use, homelessness, mental illness, loss medical social benefits. Each these areas constitutes competing priority upon release that demands immediate attention diverts time, energy, valuable resources away from engagement...
Sustained retention in HIV care (RIC) and viral suppression (VS) are central to US national prevention strategies, but have not been comprehensively assessed criminal justice (CJ) populations with known health disparities. The purpose of this study is identify predictors RIC VS following release from prison or jail.This a retrospective cohort all adult people living (PLWH) incarcerated Connecticut, US, during the period January 1, 2007, December 31, 2011, observed through 2014 (n = 1,094)....
In this paper, we reflect on health intervention translations as matters of their implementation practices. Our case is methadone treatment, an promoted globally for treating opioid dependence and preventing HIV among people who inject drugs. Tracing methadone's in high-security prisons the Kyrgyz Republic, notice multiple methadones made possible, what these afford, onto-political effects they make. We work with idea 'becoming-methadone-body' to trace making-up treatment its intra-action...
Individuals in US Immigration and Customs Enforcement (ICE) detention are at risk from serious consequences resulting the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection inadequate access to appropriate medical care. This situation represents a moral public health imperative for action by Department Homeland Security (DHS) mitigate human toll pandemic. SARS-CoV-2 emerged late 2019 Wuhan, China, causing disease (COVID-19), which has been rapidly...
Abstract Background To end the HIV and hepatitis C virus (HCV) epidemics, people who use drugs (PWUD) need more opportunities for testing. While inpatient hospitalizations are an essential opportunity to test HCV, there is limited research on rates of testing HCV among PWUD. Methods Eleven hospital sites were included in study. Each site created a cohort encounters associated with injection drug use. From these cohorts, we collected data consent policies from 65 276 PWUD hospitalizations....